Postremission therapy for acute myeloid leukemia in the first remission

References

• Weinstein H J, Mayer R J, Rosenthal D S, Coral F S, Camitta B M, Gelber R D. Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update. Blood 1983; 62: 315–319
   PubMed Web of Science ®Google Scholar
• Cassileth P A, Lynch E, Hines J D, Oken M M, Mazza J J, Bennett J M, et al. Varying intensity of postremission therapy in acute myeloid leukemia. Blood 1992; 79: 1924–1930
   PubMed Web of Science ®Google Scholar
• Schiller G, Gajewski J, Territo M, Nimer S, Lee M, Belin T, et al. Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia. Blood 1992; 80: 2977–2982
   PubMed Web of Science ®Google Scholar
• Lowenberg B, Verdonck L J, Dekker A W, Willemze R, Zwaan F E, de Planque M, et al. Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study. J Clin Oncol 1990; 8: 287–294
   PubMed Web of Science ®Google Scholar
• Cassileth P A, Andersen J, Lazarus H M, Colvin O M, Bennett J M, Stadtmauer E A, et al. Autologous bone marrow transplant in acute myeloid leukemia in first remission. J Clin Oncol 1993; 11: 314–319
   PubMed Web of Science ®Google Scholar
• Gorin N C, Aegerter P, Auvert B, Meloni G, Goldstone A H, Burnett A, et al. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood 1990; 75: 1606–1614
   PubMed Web of Science ®Google Scholar
• Sierra J, Brunet S, Granena A, Olive T, Bueno J, Ribera J M, et al. Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation. J Clin Oncol 1996; 14: 1353–1363
   PubMed Web of Science ®Google Scholar
• Schiller G J, Nimer S D, Territo M C, Ho W G, Champlin R E, Gajewski J L. Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission. J Clin Oncol 1992; 10: 41–46
   PubMed Web of Science ®Google Scholar
• Zittoun R A, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 1995; 332: 217–223
   PubMed Web of Science ®Google Scholar
• Burnett A K, Goldstone A H, Stevens R M, Hann I M, Rees J K, Gray R G, et al. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties. Lancet 1998; 351: 700–708
   PubMed Web of Science ®Google Scholar
• Harousseau J L, Cahn J Y, Pignon B, Witz F, Milpied N, Delain M, et al. Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM). Blood 1997; 90: 2978–2986
   PubMed Web of Science ®Google Scholar
• Dastugue N, Payen C, Lafage-Pochitaloff M, Bernard P, Leroux D, Huguet-Rigal F, et al. Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group. Leukemia 1995; 9: 1491–1498
   PubMed Web of Science ®Google Scholar
• Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H R, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H R, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620–625
   PubMed Web of Science ®Google Scholar
• Cheson B D, Cassileth P A, Head D R, Schiffer C A, Bennett J M, Bloomfield C D, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990; 8: 813–819
   PubMed Web of Science ®Google Scholar
• Appelbaum F R, Fisher L D, Thomas E D. Chemotherapy vs marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up. Blood 1988; 72: 179–184
   PubMed Web of Science ®Google Scholar
• Woods W G, Kobrinsky N, Buckley J, Neudorf S, Sanders J, Miller L, et al. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study. J Clin Oncol 1993; 11: 1448–1457
   PubMed Web of Science ®Google Scholar
• Reiffers J, Gaspard M H, Maraninchi D, Michallet M, Marit G, Stoppa A M, et al. Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial. Br J Haematol 1989; 72: 57–63
   PubMed Web of Science ®Google Scholar
• Ravindranath Y, Yeager A M, Chang M N, Steuber C P, Krischer J, Graham-Pole J, et al. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group. N Engl J Med 1996; 334: 1428–1434
   PubMed Web of Science ®Google Scholar